Dataset from EN20-01: A 24 Week Study to Evaluate the Safety and Efficacy of CNTX-6970 in Subjects With Moderate to Severe Knee Osteoarthritis Pain.

The primary objective of this study is to evaluate the safety and efficacy of CNTX-6970 for the treatment of pain related to OA of the knee compared to placebo. CNTX-6970 is being developed as a new treatment for chronic pain, including painful osteoarthritis of the knee.

本研究的首要目标为评估CNTX-6970与安慰剂（placebo）对照时，治疗膝关节骨关节炎（osteoarthritis）相关疼痛的安全性与有效性。CNTX-6970目前正被开发为慢性疼痛的新型治疗方案，涵盖膝关节疼痛性骨关节炎。